US$ 21.22
glp-1 protocol Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists GLP-1 medications safe to continue
Description
However, it is important to inform your doctor if you notice any persistent or worsening GI disturbances such as severe abdominal pain, nausea, vomiting, diarrhea, and unexpected weight loss

References [1] Roche data on file

However, in a subsequent cohort of diabetic patients treated for 5 weeks with liraglutide, activation of the OFC in response to food cues was increased, despite successful weight loss, improved metabolic profile, and reduced fat intake [36]

In most cases, lifestyle changes and metformin remain the most practical and evidence-based options

Steroid IOP response is much more common in patients with an existing diagnosis of glaucoma
